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An earlier edition of this Primer, covering different foodborne illnesses,
was published in MMWR in 2001 (MMWR 2001;50[No. RR-2]) and
also as a separate publication by the American Medical Association,
CDC, the Food and Drug Administration, and the U.S. Department
of Agriculture. This report updates and supplements the previous
edition. It is being reprinted here as a courtesy to the collaborating
agencies and the MMWR readers.
Diagnosis and Management of Foodborne Illnesses
A Primer for Physicians and Other Health Care Professionals
Produced collaboratively by the
American Medical Association
American Nurses Association–American Nurses Foundation
Centers for Disease Control and Prevention
Center for Food Safety and Applied Nutrition, Food and Drug Administration
Food Safety and Inspection Service, US Department of Agriculture
Preface
Foodborne illness is a serious public health problem. CDC estimates that each year 76 million people get sick, more than
300,000 are hospitalized, and 5,000 die as a result of foodborne illnesses. Primarily the very young, the elderly, and the
immunocompromised are affected. Recent changes in human demographics and food preferences, changes in food production and
distribution systems, microbial adaptation, and lack of support for public health resources and infrastructure have led to the
emergence of novel as well as traditional foodborne diseases. With increasing travel and trade opportunities, it is not surprising
that now there is a greater risk of contracting and spreading a foodborne illness locally, regionally, and even globally.
Physicians and other health care professionals have a critical role in the prevention and control of food-related disease out-
breaks. This primer is intended to provide practical and concise information on the diagnosis, treatment, and reporting of
foodborne illnesses. It was developed collaboratively by the American Medical Association, the American Nurses Association-
American Nurse Foundation, CDC, the Food and Drug Administration’s Center for Food Safety and Nutrition, and the United
States Department of Agriculture’s Food Safety and Inspection Service.
Clinicians are encouraged to review the primer and participate in the attached continuing medical education (CME) program.
Background
This primer is directed to primary care and emergency phy-
sicians, who are likely to see the index case of a potential food-
related disease outbreak. It is also a teaching tool to update
physicians and other health care professionals about foodborne
illness and remind them of their important role in recogniz-
ing suspicious symptoms, disease clusters, and etiologic agents,
and reporting cases of foodborne illness to public health
authorities.
Specifically, this guide urges physicians and other health care
professionals to
• Recognize the potential for a foodborne etiology in a
patient’s illness;
• Realize that many but not all cases of foodborne illness
have gastrointestinal tract symptoms;
• Obtain stool cultures in appropriate settings, and recog-
nize that testing for some specific pathogens, eg, E. coli
O157:H7, Vibrio spp., must be requested;
• Report suspect cases to appropriate public health officials;
• Talk with patients about ways to prevent food-related dis-
eases; and
• Appreciate that any patient with foodborne illness may
represent the sentinel case of a more widespread outbreak.
Foodborne illness is considered to be any illness that is
related to food ingestion; gastrointestinal tract symptoms are
the most common clinical manifestations of foodborne ill-
nesses. This document provides detailed summary tables and
charts, references, and resources for health care professionals.
Patient scenarios and clinical vignettes are included for self-
evaluation and to reinforce information presented in this
primer. Also included is a CME component.
This primer is not a clinical guideline or definitive resource
for the diagnosis and treatment of foodborne illness. Safe food
handling practices and technologies (eg, irradiation, food pro-
cessing and storage) also are not addressed. More detailed
information on these topics is available in the references and
resources listed in this document, as well as from medical spe-
cialists and medical specialty societies, state and local public
health authorities, and federal government agencies.
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For additional copies, please contact
Litjen (L.J.) Tan, PhD
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Or visit the following websites:
The American Medical Association
http://www.ama-assn.org/go/foodborne
Centers for Disease Control and Prevention
http://www.cdc.gov/foodsafety/cme.htm
Center for Food Safety and Applied Nutrition,
Food and Drug Administration
http://www.cfsan.fda.gov




Food-related disease threats are numerous and varied,
involving biological and nonbiological agents. Foodborne ill-
nesses can be caused by microorganisms and their toxins,
marine organisms and their toxins, fungi and their related
toxins, and chemical contaminants. During the last 20 years,
some foods that have been linked to outbreaks include milk
(Campylobacter); shellfish (noroviruses); unpasteurized apple
cider (Escherichia coli O157:H7), raw and undercooked eggs
(Salmonella); fish (ciguatera poisoning); raspberries (Cyclospora);
strawberries (hepatitis A virus); and ready-to-eat meats (Listeria).
While physicians and other health care professionals have a
critical role in surveillance for and prevention of potential dis-
ease outbreaks, only a fraction of the people who experience
gastrointestinal tract symptoms from foodborne illness seek
medical care. In those who do seek care and submit speci-
mens, bacteria are more likely than other pathogens to be iden-
tified as causative agents. Bacterial agents most often identified
in patients with foodborne illness in the United States are
Campylobacter, Salmonella, and Shigella species, with substan-
tial variation occurring by geographic area and season. Test-
ing for viral etiologies of diarrheal disease is rarely done in
clinical practice, but viruses are considered the most common
cause of foodborne illness.
This section and the accompanying Foodborne Illnesses
Tables summarize diagnostic features and laboratory testing
for bacterial, viral, parasitic, and noninfectious causes of
foodborne illness. For more specific guidance, consult an
appropriate medical specialist or medical specialty society, as
well as the various resources listed in this primer. Also refer to
this section and the accompanying Foodborne Illnesses Tables
when working through the various Patient Scenarios and the
Clinical Vignettes portion of this primer.
Recognizing Foodborne Illness
Patients with foodborne illnesses typically present with
gastrointestional tract symptoms (eg, vomiting, diarrhea,
abdominal pain); however, nonspecific symptoms and neuro-
logic symptoms may also occur. Every outbreak begins with
an index patient who may not be severely ill. A physician or
health care professional who encounters this person may be
the only one with the opportunity to make an early and expe-
ditious diagnosis. Thus, the physician or health care profes-
sional must have a high degree of suspicion and ask appropriate
questions to recognize that an illness may have a foodborne
etiology.
Important clues to determining the etiology of a foodborne
disease are the
• Incubation period;
• Duration of the resultant illness;
• Predominant clinical symptoms; and
• Population involved in the outbreak.
Additional clues may be derived by asking whether the
patient has consumed raw or poorly cooked foods (eg, raw or
undercooked eggs, meats, shellfish, fish), unpasteurized milk
or juices, home-canned goods, fresh produce, or soft cheeses
made from unpasteurized milk. Inquire as to whether any of
the patient’s family members or close friends have similar symp-
toms. Inquiries about living on or visiting a farm, pet contact,
day care attendance, occupation, foreign travel, travel to coastal
areas, camping excursions to mountains or other areas where
untreated water is consumed, and attendance at group pic-
nics or similar outings also may provide clues for determining
the etiology of the illness.
If a foodborne illness is suspected, submit appropriate speci-
mens for laboratory testing and contact the state or local health
department for advice about epidemiologic investigation. For
the physician or other health care professional, implication of
a specific source in disease transmission is difficult from a single
patient encounter. Attempts to identify the source of the out-
break are best left to public health authorities.
Because infectious diarrhea can be contagious and is easily
spread, rapid and definitive identification of an etiologic agent
may help control a disease outbreak. Early identification of a case
of foodborne illness can prevent further exposures. An individual
physician who obtains testing can contribute the clue that ulti-
mately leads to identification of the source of an outbreak.
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Finally, health care professionals should recognize that while
deliberate contamination of food is a rare event, it has been
documented in the past. The following events may suggest
that intentional contamination has occurred: an unusual agent
or pathogen in a common food, a common agent or patho-
gen affecting an unusually large number of people, or a com-
mon agent or pathogen that is uncommonly seen in clinical
practice, as might occur with pesticide poisoning.
Diagnosing Foodborne Illnesses
Differential Diagnosis
As shown in Table 1 and the Foodborne Illnesses Tables, a
variety of infectious and noninfectious agents should be con-
sidered in patients suspected of having a foodborne illness.
Establishing a diagnosis can be difficult, however, particularly
in patients with persistent or chronic diarrhea, those with
severe abdominal pain, and when there is an underlying dis-
TABLE 1. Etiologic agents to consider for various manifestations of foodborne illness
Clinical presentation
Gastroenteritis (vomiting as primary
symptom; fever and/or diarrhea also
may be present)
Noninflammatory diarrhea (acute watery
diarrhea without fever/dysentery; some
patients may present with fever)*
Inflammatory diarrhea (invasive
gastroenteritis; grossly bloody stool and
fever may be present)†
Persistent diarrhea (lasting >14 days)
Neurologic manifestations (eg,
paresthesias, respiratory depression,
bronchospasm, cranial nerve palsies)
Systemic illness (eg, fever, weakness,
arthritis, jaundice)
Potential food-related agents to consider
Viral gastroenteritis, most commonly rotavirus in an infant or norovirus and other caliciviruses in an older
child or adult; or food poisoning due to preformed toxins (eg, vomitoxin, Staphylococcus aureus toxin,
Bacillus cereus toxin) and heavy metals.
















Prolonged illness should prompt examination for parasites, particularly in travelers to mountainous or
other areas where untreated water is consumed. Consider Cyclospora cayetanensis, Cryptosporidium,
Entamoeba histolytica, and Giardia lamblia.
Botulism (Clostridium botulinum toxin)
Organophosphate pesticides
Thallium poisoning
Scombroid fish poisoning (histamine, saurine)
Ciguatera fish poisoning (ciguatoxin)
Tetradon fish poisoning (tetradotoxin)
Neurotoxic shellfish poisoning (brevitoxin)
Paralytic shellfish poisoning (saxitoxin)
Amnesic shellfish poisoning (domoic acid)
Mushroom poisoning






Hepatitis A and E viruses
Salmonella Typhi and Salmonella Paratyphi
Amebic liver abscess
* Noninflammatory diarrhea is characterized by mucosal hypersecretion or decreased absorption without mucosal destruction and generally involves the
small intestine. Some affected patients may be dehydrated because of severe watery diarrhea and may appear seriously ill. This is more common in the
young and the elderly. Most patients experience minimal dehydration and appear mildly ill with scant physical findings. Illness typically occurs with abrupt
onset and brief duration. Fever and systemic symptoms usually are absent (except for symptoms related directly to intestinal fluid loss).
† Inflammatory diarrhea is characterized by mucosal invasion with resulting inflammation and is caused by invasive or cytotoxigenic microbial pathogens.
The diarrheal illness usually involves the large intestine and may be associated with fever, abdominal pain and tenderness, headache, nausea, vomiting,
malaise, and myalgia. Stools may be bloody and may contain many fecal leukocytes.
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ease process. The extent of diagnostic evaluation depends on
the clinical picture, the differential diagnosis considered, and
clinical judgment.
The presentation of a patient with a foodborne illness is
often only slightly different from that of a patient who pre-
sents with a viral syndrome. In addition, viral syndromes are
so common that it is reasonable to assume that a percentage
of those diagnosed with a viral syndrome have actually con-
tracted a foodborne illness. Therefore, the viral syndrome must
be excluded in order to suspect the foodborne illness and take
appropriate public health action. Fever, diarrhea, and abdomi-
nal cramps can be present or absent in both cases so they are
not very helpful. The absence of myalgias or arthralgias would
make a viral syndrome less likely and a foodborne illness (that
does not target the neurologic system) more likely. Foodborne
illnesses that do target the neurologic system tend to cause
paraesthesias, weakness and paralysis that are distinguishable
from myalgias or arthralgias (see below). The presence of dys-
entery (bloody diarrhea) is also more indicative of a foodborne
illness, particularly if it is early in the course.
If any of the following signs and symptoms occur in patients,
either alone or in combination, laboratory testing may pro-
vide important diagnostic clues (particular attention should
be given to very young and elderly patients and to immuno-
compromised patients, all of whom are more vulnerable):
• Bloody diarrhea
• Weight loss
• Diarrhea leading to dehydration
• Fever
• Prolonged diarrhea (3 or more unformed stools per day,
persisting several days)
• Neurologic involvement, such as paresthesias, motor weak-
ness, cranial nerve palsies
• Sudden onset of nausea, vomiting, diarrhea
• Severe abdominal pain
In addition to foodborne causes, a differential diagnosis of
gastrointestinal tract disease should include underlying medi-
cal conditions such as irritable bowel syndrome; inflamma-
tory bowel diseases such as Crohn’s disease or ulcerative colitis;
malignancy; medication use (including antibiotic-related
Clostridium difficile toxin colitis); gastrointestinal tract sur-
gery or radiation; malabsorption syndromes; immune defi-
ciencies; and numerous other structural, functional, and
metabolic etiologies. Consideration also should be given to
exogenous factors such as the association of the illness with
travel, occupation, emotional stress, sexual habits, exposure
to other ill persons, recent hospitalization, child care center
attendance, and nursing home residence.
The differential diagnosis of patients presenting with neuro-
logic symptoms due to a foodborne illness is also complex. Pos-
sible food-related causes to consider include recent ingestion of
contaminated seafood, mushroom poisoning, and chemical
poisoning. Because the ingestion of certain toxins (eg, botuli-
num toxin, tetrodotoxin) and chemicals (eg, organophosphates)
can be life-threatening, a differential diagnosis must be made
quickly with concern for aggressive therapy and life support
measures (eg, respiratory support, administration of antitoxin
or atropine), and possible hospital admission.
Clinical Microbiology Testing
When submitting specimens for microbiologic testing, it is
important to realize that clinical microbiology laboratories
differ in protocols used for the detection of pathogens. To
optimize recovery of an etiologic agent, physicians and other
health care professionals should understand routine specimen-
collection and testing procedures as well as circumstances and
procedures for making special test requests. Some complex
tests (eg, toxin testing, serotyping, molecular techniques) may
only be available from large commercial or public health labo-
ratories. Contact your microbiology laboratory for more
information.
Stool cultures are indicated if the patient is immuno-
compromised, febrile, has bloody diarrhea, has severe abdomi-
nal pain, or if the illness is clinically severe or persistent. Stool
cultures are also recommended if many fecal leukocytes are
present. This indicates diffuse colonic inflammation and is
suggestive of invasive bacterial pathogens such as Shigella,
Salmonella, and Campylobacter species and invasive E. coli. In
most laboratories, routine stool cultures are limited to screen-
ing for Salmonella and Shigella species and Campylobacter
jejuni/coli. Cultures for Vibrio and Yersinia species, E. coli
O157:H7, and Campylobacter species other than jejuni/coli
require additional media or incubation conditions and there-
fore require advance notification or communication with labo-
ratory and infectious disease personnel.
Stool examination for parasites generally is indicated for
patients with suggestive travel histories, who are immuno-
compromised, who suffer chronic or persistent diarrhea, or
when the diarrheal illness is unresponsive to appropriate anti-
microbial therapy. Stool examination for parasites is also indi-
cated for gastrointestinal tract illnesses that appear to have a
long incubation period. Requests for ova and parasite exami-
nation of a stool specimen will often enable identification of
Giardia lamblia and Entamoeba histolytica, but a special
request may be needed for detection of Cryptosporidium and
Cyclospora cayetanensis. Each laboratory may vary in its rou-
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tine procedures for detecting parasites, so it is important to
contact your laboratory.
Blood cultures should be obtained when bacteremia or sys-
temic infection is suspected.
Direct antigen detection tests and molecular biology tech-
niques are available for rapid identification of certain bacterial,
viral, and parasitic agents in clinical specimens. In some cir-
cumstances, microbiologic and chemical laboratory testing of
vomitus or implicated food items also is warranted. For more
information on laboratory procedures for the detection of
foodborne pathogens, consult an appropriate medical special-
ist, clinical microbiologist, or state public health laboratory.
Treating Foodborne Illness
Selection of appropriate treatment depends on identifica-
tion of the responsible pathogen (if possible) and determin-
ing if specific therapy is available. Many episodes of acute
gastroenteritis are self-limiting and require fluid replacement
and supportive care. Oral rehydration is indicated for patients
who are mildly to moderately dehydrated; intravenous therapy
may be required for more severe dehydration. Routine use of
antidiarrheal agents is not recommended because many of these
agents have potentially serious adverse effects in infants and
young children.
Choice of antimicrobial therapy should be based on
• Clinical signs and symptoms;
• Organism detected in clinical specimens;
• Antimicrobial susceptibility tests; and
• Appropriateness of treating with an antibiotic (some
enteric bacterial infections are best not treated).
Knowledge of the infectious agent and its antimicrobial sus-
ceptibility pattern allows the physician to initiate, change, or
discontinue antimicrobial therapy. Such information also can
support public health surveillance of infectious disease and
antimicrobial resistance trends in the community. Antimicro-
bial resistance has increased for some enteric pathogens, which
dictates judicious use of this therapy.
Suspected cases of botulism are treated with botulinum
antitoxin. Equine botulinum antitoxin for types A, B, and E
can prevent the progression of neurologic dysfunction if
administered early in the course of illness. Physicians and other
health care professionals should notify their local and state
health departments regarding suspected cases of botulism.
CDC maintains a 24-hour consultation service to assist health




Reporting of foodborne illnesses in the United States began
more than 50 years ago when state health officers, concerned
about the high morbidity and mortality caused by typhoid
fever and infantile diarrhea, recommended that cases of
“enteric fever” be investigated and reported. The intent of
investigating and reporting these cases was to obtain informa-
tion about the role of food, milk, and water in outbreaks of
gastrointestinal tract illness as the basis for public health
actions. These early reporting efforts led to the enactment of
important public health measures (eg, the Pasteurized Milk
Ordinance) that profoundly decreased the incidence of
foodborne illnesses.
Often health care professionals may suspect foodborne ill-
ness either because of the organism involved or because of
other available information, such as several ill patients who
have eaten the same food. Health care professionals can serve
as the eyes and ears for the health department by providing
such information to local or state public health authorities.
Foodborne disease reporting is not only important for disease
prevention and control, but more accurate assessments of the
burden of foodborne illness in the community occur when
physicians and other health care professionals report foodborne
illnesses to the local and state health department. In addition,
reporting of cases of foodborne illness by practicing physi-
cians to the local health department may help the health
officer identify a foodborne disease outbreak in the commu-
nity. This may lead to early identification and removal of con-
taminated products from the commercial market. If a
restaurant or other food service establishment is identified as
the source of the outbreak, health officers will work to correct
inadequate food preparation practices, if necessary. If the home
is the likely source of the contamination, health officers can
institute public education about proper food handling prac-
tices. Occasionally, reporting may lead to the identification of
a previously unrecognized agent of foodborne illness. Report-
ing also may lead to identification and appropriate manage-
ment of human carriers of known foodborne pathogens,
especially those with high-risk occupations for disease trans-
mission such as foodworkers.
Table 2 lists current reporting requirements for foodborne
diseases and conditions in the United States. National report-
ing requirements are determined collaboratively by the Council
of State and Territorial Epidemiologists and CDC. Additional
reporting requirements may also be mandated by state and
territorial laws and regulations. Details on specific state
reporting requirements are available from state health depart-
6 MMWR April 16, 2004
TABLE 2. Foodborne diseases and conditions designated as
notifiable at the national level* — United States 2003






Hemolytic uremic syndrome, post-diarrheal
Listeriosis
Salmonellosis (other than S. Typhi)
Shigellosis
Typhoid fever (S. Typhi and S. Paratyphi infections)
Notifiable VIRAL foodborne diseases and conditions
Hepatitis A





In the United States, additional reporting requirements may be
mandated by state and territorial laws and regulations. Details on
specific state reporting requirements are available from state health
departments and from the
Council of State and Territorial Epidemiologists (phone
number: 770-458-3811). Information available electronically at:
www.cste.org/nndss/reportingrequirements.htm.
Centers for Disease Control and Prevention. Information
available electronically at www.cdc.gov/epo/dphsi/phs/
infdis2003.htm.
ments and from the Council of State and Territorial Epidemi-
ologists and CDC.
Typically, the appropriate procedure for health care profes-
sionals to follow in reporting foodborne illnesses is to contact
the local or state health department whenever they identify a
specific notifiable foodborne disease. However, it is often
unclear if a patient has a foodborne illness prior to diagnostic
tests, so health care professionals should also report potential
foodborne illnesses, such as when 2 or more patients present
with a similar illness that may have resulted from the inges-
tion of a common food. Local health departments then
report the illnesses to the state health departments and deter-
mine if further investigation is warranted.
Each state health department reports foodborne illnesses to
CDC. CDC compiles these data nationally and disseminates
information via the weekly Morbidity and Mortality Weekly
Report and annual summary reports. CDC assists state and
local public health authorities with epidemiologic investigations
and the design of interventions to prevent and control food-
related outbreaks. CDC also coordinates a national network of
public health laboratories, called PulseNet, which performs
“molecular fingerprinting” of bacteria (by pulsed-field gel elec-
trophoresis) to support epidemiologic investigations.
Thus, in addition to reporting cases of potential foodborne
illnesses, it is important for physicians to report noticeable
increases in unusual illnesses, symptom complexes, or disease
patterns (even without definitive diagnosis) to public health
authorities. Prompt reporting of unusual patterns of diarrheal/
gastrointestinal tract illness, for example, can allow public
health officials to initiate an epidemiologic investigation ear-
lier than would be possible if the report awaited definitive
etiologic diagnosis.
Finally, new information on food safety is constantly emerg-
ing. Recommendations and precautions for people at high
risk are updated whenever new data about preventing
foodborne illness become available. Physicians and other health
care professionals need to be aware of and follow the most
current information on food safety.
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 Foodborne Illnesses (Bacterial)
Incubation Duration of








































Sudden onset of severe
nausea and vomiting.



















control, poor gag and
sucking reflex.
Watery diarrhea, nausea,
abdominal cramps; fever is
rare.
Severe diarrhea that is
often bloody, abdominal
pain and vomiting. Usually,
little or no fever is present.












































bottled garlic, foods held
warm for extended





















laboratories do not routinely
identify this organism. If





Testing not necessary, self-
limiting (consider testing
food and stool for toxin in
outbreaks).





incubation at 42°C to grow.
Stool, serum, and food can
be tested for toxin. Stool
and food can also be
cultured for the organism.
These tests can be
performed at some state
health department
laboratories and CDC.
Stool, serum, and food can
be tested for toxin. Stool
and food can also be
cultured for the organism.
These tests can be
performed at some state
health department
laboratories and CDC.
Stools can be tested for
enterotoxin and cultured for
organism. Because
Clostridium perfringens can
normally be found in stool,
quantitative cultures must
be done.
Stool culture; E. coli
O157:H7 requires special
media to grow. If E. coli
O157:H7 is suspected,
specific testing must be
requested. Shiga toxin
testing may be done using
commercial kits; positive
isolates should be
forwarded to public health
laboratories for confirmation
and serotyping.
Penicillin is first choice for
naturally acquired gastrointes-





doxycycline daily for >6 weeks.
Infections with complications
require combination therapy
with rifampin, tetracycline, and
an aminoglycoside.
Supportive care. For severe
cases, antibiotics such as
erythromycin and quinolones
may be indicated early in the
diarrheal disease. Guillain-
Barré syndrome can be a
sequela.
Supportive care. Botulinum
antitoxin is helpful if given
early in the course of the
illness. Contact the state
health department. The 24-
hour number for state health
departments to call is (770)
488-7100.
Supportive care. Botulism
immune globulin can be
obtained from the Infant
Botulism Prevention Program,
Health and Human Services,
California (510-540-2646).
Botulinum antitoxin is generally
not recommended for infants.
Supportive care. Antibiotics not
indicated.
Supportive care, monitor renal
function, hemoglobin, and
platelets closely. E. coli
O157:H7 infection is also
associated with hemolytic
uremic syndrome (HUS), which
can cause lifelong complica-
tions. Studies indicate that
antibiotics may promote the
development of HUS.
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 Foodborne Illnesses (Bacterial) (Continued)
Incubation Duration of

































Fever, muscle aches, and
nausea or diarrhea.
Pregnant women may
have mild flu-like illness,







mother at risk for sepsis or
meningitis.
Diarrhea, fever, abdominal
cramps, vomiting. S. Typhi







and vomiting is not usually
severe.
Abdominal cramps, fever,
and diarrhea. Stools may
contain blood and mucus.
Sudden onset of severe
nausea and vomiting.
Abdominal cramps.
Diarrhea and fever may be
present.
Profuse watery diarrhea
and vomiting, which can
lead to severe dehydration









mised, or in patients with
chronic liver disease
(presenting with bullous
skin lesions). Can be fatal























deli meats, hot dogs.
Contaminated eggs,
poultry, unpasteurized



























from Latin America or
Asia.
Undercooked or raw











tion. If suspected, must
request specific testing.





Antibody to listerolysin O






and food can be tested for




media to grow. If V.








Stool, wound, or blood
cultures. Vibrio vulnificus
requires special media to










ampicillin, penicillin, or TMP-
SMX are recommended for
invasive disease.
Supportive care. Other than for
S. Typhi and S. Paratyphi,
antibiotics are not indicated
unless there is extra-intestinal
spread, or the risk of extra-
intestinal spread, of the
infection. Consider ampicillin,
gentamicin, TMP-SMX, or
quinolones if indicated. A
vaccine exists for S. Typhi.
Supportive care. TMP-SMX
recommended in the US if
organism is susceptible;
nalidixic acid or other






aggressive oral and intra-
venous rehydration. In cases of
confirmed cholera, tetracycline
or doxycycline is recommended
for adults, and TMP-SMX for
children (<8 years).
Supportive care. Antibiotics
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 Foodborne Illnesses (Bacterial) (Continued)
Incubation Duration of





24–48 hrs Appendicitis-like symptoms
(diarrhea and vomiting,
fever, and abdominal pain)
occur primarily in older
children and young adults.
May have a scarlitiniform












Stool, vomitus, or blood
culture. Yersinia requires
special media to grow. If
suspected, must request
specific testing. Serology is
available in research and
reference laboratories.
Supportive care. If septicemia
or other invasive disease




 Foodborne Illnesses (Viral)
Incubation Duration of
























Diarrhea is more prevalent
in adults and vomiting is













































Increase in ALT, bilirubin.
Positive IgM and anti-
hepatitis A antibodies.
Routine RT-PCR and EM
on fresh unpreserved stool
samples. Clinical diagnosis,
negative bacterial cultures.
Stool is negative for WBCs.
Identification of virus in
stool via immunoassay.
Identification of the virus in
early acute stool samples.
Serology. Commercial





Supportive care such as
rehydration. Good hygiene.
Supportive care. Severe
diarrhea may require fluid and
electrolyte replacement.
Supportive care, usually mild,
self-limiting. Good hygiene.
 Foodborne Illnesses (Parasitic)
Incubation Duration of










































snails or slugs), infected
paratenic (transport)





Any uncooked food or
food contaminated by
an ill food handler after
cooking, drinking water.
Various types of fresh
produce (imported
berries, lettuce).









examination of the stool for
Cryptosporidium. May need
to examine water or food.
Request specific
examination of the stool for
Cyclospora. May need to
examine water or food.
Supportive care. Repeat
lumbar punctures and use of
corticosteroid therapy may be
used for more severely ill
patients.
Supportive care, self-limited. If
severe consider paromomycin
for 7 days. For children aged
1–11 years, consider
nitazoxanide for 3 days.
TMP-SMX for 7 days.
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 Foodborne Illnesses (Parasitic) (Continued)
Incubation Duration of



































tis is often seen.
Treatment of the mother
may reduce severity and/
or incidence of congenital
infection. Most infected
infants have few
symptoms at birth. Later,

























Any uncooked food or
food contaminated by
an ill food handler after
cooking, drinking water.
Any uncooked food or
food contaminated by





with cat feces on fruits










usually pork or wild
game meat (eg, bear or
moose).
Examination of stool for
cysts and parasites—may
need at least 3 samples.
Serology for long-term
infections.
Examination of stool for ova
and parasites — may need
at least 3 samples.
Isolation of parasites from
blood or other body fluids;
observation of parasites in
patient specimens via
microscopy or histology.
Detection of organisms is
rare; serology (reference
laboratory needed) can be
a useful adjunct in
diagnosing toxoplasmosis.
However, IgM antibodies
may persist for 6–18
months and thus may not
necessarily indicate recent
infection. PCR of bodily
fluids. For congenital
infection: isolation of
T. gondii from placenta,
umbilical cord, or infant
blood. PCR of white blood
cells, CSF, or amniotic
fluid, or IgM and IgA
serology, performed by a
reference laboratory.
Positive serology or
demonstration of larvae via
muscle biopsy. Increase in
eosinophils.





infected, persons do not
require treatment. Spiramycin
or pyrimethamine plus
sulfadiazine may be used
for pregnant women.
Pyrimethamine plus
sulfadiazine may be used
for immunocompromised
persons, in specific cases.
Pyrimethamine plus
sulfadiazine (with or without
steroids) may be given for
ocular disease when indicated.
Folinic acid is given with
pyrimethamine plus sulfadiaz-
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 Foodborne Illnesses (Noninfectious)
Incubation Duration of
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Identification of metal in
food.
Radioassay for toxin in fish
or a consistent history.
Identification of metal in
beverage or food.
Analysis of blood, hair.
Typical syndrome and
mushroom identified or
demonstration of the toxin.
Typical syndrome and
mushroom identified and/or
demonstration of the toxin.
Analysis of the food, blood.
Analysis of the food, blood.
Detection of tetrodotoxin in
fish.
Demonstration of histamine
















is used when atropine is not
able to control symptoms and






12 MMWR April 16, 2004
 Foodborne Illnesses (Noninfectious) (Continued)
Incubation Duration of
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lips, tongue, and throat,
muscular aches, dizziness,
reversal of the sensations










































A variety of shellfish,
primarily mussels,
oysters, scallops, and
shellfish from the Florida













Grains such as wheat,
corn, barley.
Metallic container.
Detection of the toxin in
shellfish; high-pressure
liquid chromatography.
Detection of toxin in food or
water where fish are
located; high-pressure
liquid chromatography.




Analysis of the food.
Analysis of the food.
Analysis of the food, blood
and feces, saliva or urine.
Supportive care, generally self-
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Patient Scenarios
The learning scenarios in this section can be used to rein-
force medical management information pertaining to
foodborne illnesses, such as that provided from the previous
sections of this primer. The case studies provide questions that
need to be considered when dealing with a potential case of
foodborne illness. Answers are provided immediately follow-
ing the questions to enhance the learning process.
Similar learning scenarios are also available for other
foodborne pathogens.
Congenital Toxoplasmosis, A Patient
Scenario
Susan, a 6-month-old infant, is brought to your office for
evaluation of apparent blindness. Her mother reports that she
had been well during the pregnancy and the delivery was
uncomplicated. The baby appeared healthy until age 4 months,
when the parents became concerned about her vision.
Physical examination was normal except for bilateral macu-
lar scars, microphthalmos, and unresponsiveness to visual
stimuli. There were no other neurologic abnormalities, and
her growth and development were appropriate for her age. A
computed tomography (CT) scan of the head was obtained.
Congenital infection with which of the












What additional information would assist
with the diagnosis?
• More history from the mother, including travel to for-
eign country
• Vaccination record, including during pregnancy
• History of exposure to cats and raw meat
• History of multiple sex partners and sexually transmit-
ted disease (STD)
• History of herpes
• Evaluation of CT scan
The CT scan of the child’s head showed periventricular cal-
cifications and asymmetric dilation of the lateral ventricles.
The mother is 35 years old and reiterated that she does not
recall being ill during the pregnancy; however, she also indi-
cated that she would not necessarily remember every little
symptom. She also denied having a history of STDs. She had
received the mumps-measles-rubella (MMR) vaccine as a child
but no vaccines during pregnancy. The mother recalled eating
insufficiently cooked meat while traveling in France during
the first trimester of pregnancy. The family does not own a
cat, and she does not recall having been exposed to cats dur-
ing her pregnancy.
What diagnostic tests are needed?
Serologic evaluation of both mother and child focusing
on potential congenital infection (ie, a ToRCH profile)
based on the history of the mother ingesting raw meat
while traveling in a foreign country during first trimester
of pregnancy and the clinical findings (blindness, cere-
bral calcifications, and hydrocephalus).
Results of serologic testing detected both IgG and IgM
antibodies to Toxoplasma gondii in both the baby’s and
mother’s serum. The mother’s IgM titer was 1:6400 and
IgG titer was 1:6400, while those of the baby were IgM
titer of 1:160 and IgG titer of 1:6400.
How does this information assist with the
diagnosis?
Diagnosis of toxoplasmosis is usually confirmed by
serologic tests. Occasionally, organisms are identified in
tissue or body fluids or isolated by culture or animal
inoculation. Polymerase chain reaction (PCR)-based
assays are available from some laboratories for diagnosis
of fetal infection and infection in compromised hosts.
For immunocompetent persons, seroconversion or a
4-fold rise of specific IgG antibodies or demonstration of
specific IgM antibodies indicate recent infection. High
titers of IgG antibodies in the absence of IgM antibodies
are consistent with chronic latent infection acquired in
the past. The IgM-capture enzyme-linked immunosorbent
assay (ELISA) is more sensitive than the IgM-indirect fluo-
rescent-antibody assay (IFA) test. However, IgM tests may
be false-positive, and true-positive IgM tests may persist
for a year or more. Therefore, to determine if infection
occurred during pregnancy, additional tests, such as an
anti-Toxoplasma avidity test, may be required at a refer-
ence laboratory.
14 MMWR April 16, 2004
Immunodeficient persons usually do not have measur-
able IgM antibodies, even in the presence of active dis-
ease. The diagnosis of central nervous system (CNS)
toxoplasmosis in such persons is therefore based on clini-
cal picture, typical CT scan or magnetic resonance imag-
ing (MRI) showing multiple ring-enhancing hypodense
nodules, and a positive IgG test. Brain biopsy is reserved
for cases that fail to respond to an empiric trial of anti-
Toxoplasma drugs.
The baby was diagnosed with congenital toxoplasmosis.
How is toxoplasmosis best treated?
Toxoplasmosis in immunocompetent persons rarely
requires treatment, whereas infection in immunodeficient
persons or in infants with congenital infections usually
requires treatment. The combination of pyrimethamine
and sulfadiazine is the treatment of choice. Folinic acid
(leucovorin) is given to prevent bone marrow suppres-
sion. Treatment must be continued for the duration of
immunosuppression and for life in AIDS patients whose
immunity is not reconstituted by highly aggressive
antiretroviral therapy (HAART).
For persons unable to tolerate the pyrimethamine and
sulfadiazine combination, high doses of pyrimethamine
(and leucovorin) and clindamycin are effective.
The management of toxoplasmosis acquired during preg-
nancy is controversial. Testing of newly pregnant women
for T. gondii infection is not routinely done, and routine
testing is not recommended by CDC or by the American
College of Obstetricians and Gynecologists. To prevent
fetal infection, one approach is to administer spiramycin (a
macrolide antibiotic, which is concentrated in the placenta
and is not harmful to the fetus). At the same time, amni-
otic fluid is submitted for PCR-based testing to determine
whether fetal infection has occurred. If so, options may
include pyrimethamine and sulfadiazine given after the 16th
week of pregnancy (since pyrimethamine is potentially ter-
atogenic) or consideration of terminating the pregnancy. If
the fetus is shown to be uninfected, spiramycin is contin-
ued throughout pregnancy.
Different protocols exist for treatment of infants born
with congenital infection. The most commonly recom-
mended treatment is pyrimethamine and sulfadiazine plus
leucovorin during the first year of life. In the present case,
the child was treated for 6 months with pyrimethamine
and sulfadiazine plus leucovorin.
Human infection with the intracellular protozoan parasite
Toxoplasma gondii occurs globally. Infection is usually sub-
clinical or produces a mild illness, except in immunodeficient
persons and fetuses infected in utero. Most infants with con-
genital toxoplasmosis appear healthy at birth but have a high
incidence of developing serious ophthalmologic and neuro-
logic sequelae during the next 20 years of life. Severe congeni-
tal toxoplasmosis may be apparent at birth or become apparent
during the first 6 months of life. Chorioretinitis, intracerebral
calcifications, and hydrocephalus, as in the present case, are
typical features
The child was treated with pyrimethamine, sulfadiazine, and
folinic acid for 6 months. She remains blind, and has devel-
oped moderate psychomotor retardation.
How could Toxoplasma infection have
been prevented in this child?
Toxoplasma gondii may be transmitted transplacentally
to the fetus if the mother acquired toxoplasmosis during
pregnancy. There is almost no risk of transplacental trans-
mission if the mother was infected prior to conception;
accordingly, women with positive IgG antibody tests for
toxoplasmosis at the onset of pregnancy are not at risk for
developing acute toxoplasmosis. Women with negative
IgG antibody tests during pregnancy should avoid eating
insufficiently cooked or uncooked meat and should avoid
ingestion of soil and water or food that may be contami-
nated with cat feces.
Transmission occurs by a) ingestion of tissue cysts in
raw or insufficiently cooked meat, especially lamb, pork,
and wild game; b) accidental ingestion of food, water, or
soil contaminated with cat feces that contain infective
oocysts; c) transplacental passage of infective tachyzoites;
d) transfusion of infected white blood cells or transplan-
tation of an infected organ; and e) laboratory accidents.
Prevention of toxoplasmosis is particularly important
for uninfected (ie, seronegative) pregnant mothers, HIV-
infected persons, and other immunocompromised
patients:
• Avoid ingestion of raw or insufficiently cooked meat
and poultry; cook meat to 160°F (71°C) or freeze to -4°F
(-20°C). For more details on preventing toxoplasmo-
sis, please see the Suggested Resources and Suggested
Reading List.
• Avoid ingestion of environmental oocysts by avoiding
contact with cat litter, soil, water, and vegetables
potentially contaminated with cat feces.
Vol. 53 / RR-4 Recommendations and Reports 15
Infection acquired by healthy persons is usually asymptom-
atic or may lead to painless lymphadenopathy or a mononucleo-
sis syndrome. Maternal infection is usually unrecognized.
Disease in persons with depressed cellular immunity (eg,
persons with AIDS, transplant recipients, persons receiving
immunosuppressants) usually is due to reactivation of latent
infection but can result from acute infection. Toxoplasmosis
in these persons leads to lethal meningoencephalitis, focal
lesions of the CNS, and less commonly, myocarditis or pneu-
monitis. The clinical picture may include headache, seizures,
mental status changes, focal neurologic signs, and aseptic
meningitis. Thirty to forty percent of AIDS patients with IgG
antibodies to T. gondii (indicating chronic latent infection)
develop active toxoplasmosis unless they take preventive medi-
cation.
Congenital infection occurs when a previously uninfected
mother develops infection during pregnancy. Infection prior
to conception, demonstrated by specific IgG antibodies, in
nearly all cases guarantees against infection of the fetus. How-
ever, transplacental transmission occurs from mothers whose
prior infections reactivate when they receive immunosuppres-
sant medications or develop AIDS. Congenital toxoplasmosis
may result in abortion, stillbirth, mental retardation, and reti-
nal damage. Recurrent toxoplasmic chorioretinitis in children
and young adults is frequently the result of congenital infec-
tion that was asymptomatic at birth.
Acute Hepatitis A: A Patient Scenario
While working in an emergency room, you are asked to see
a 31-year-old Asian-American woman who has had fever,
nausea, and fatigue for the past 24 hours. She also reports
dark urine and has had 3 light colored stools since yesterday.
She has previously been healthy and has no previous history
of jaundice. Her physical examination shows a low-grade
fever of 100.6°F/38.1°C, faint scleral icterus, and hepatome-
galy. Her blood pressure and neurologic exam are normal and
there is no rash. Initial laboratory studies show an alanine ami-
notransferase (ALT) result of 877 IU/L, aspartate amino trans-
ferase (AST) enzyme levels of 650 IU/L, an alkaline phosphatase
of 58 IU/L and a total bilirubin of 3.4 mg/dL. White blood cell
count is 4.6, with a normal differential; electrolytes are normal;
the blood urea nitrogen level is 18 mg/dL; and serum creati-
nine level is 0.6 mg/dL. Pregnancy test is negative.
What should be included in the differential
diagnosis of acute hepatitis?
• Viral infections:























— alcohol, carbon tetrachloride
• Autoimmune disease:
— autoimmune hepatitis
— systemic lupus erythematosus
What additional information would assist
with the diagnosis?
• Has she traveled outside the United States recently?
• Does she use illicit drugs?
• Is anyone else in the household ill?
• How many sex partners has she had in the past 6 months?
• Does she have regular contact with animals?
• What medications is she taking?
• Has she ever had a transfusion?
• Does she drink alcohol?
• Does she take care of children?
• Has she ever received hepatitis B vaccination?
• Has she ever received hepatitis A vaccination?
• Did she receive immune globulin within the past 3 months?
• What is her occupation?
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She has no children, and her boyfriend is not ill. She has
been in a monogamous relationship with her boyfriend for 2
years. She was born in the United States; her parents immi-
grated to the United States from Taiwan in the 1950s. She
works as a food preparer for a catering business. She returned
4 weeks ago from a 1-week vacation in Mexico (Mexico City
and nearby areas), where she stayed with her boyfriend in sev-
eral hotels. She drank only bottled water but ate both cooked
and uncooked food at numerous restaurants while in Mexico,
and she visited a family friend and her 3 young children in a
Mexico City suburb.
She did not receive hepatitis A vaccine or immune globulin
before going on vacation. She is not sure if she has received
hepatitis B vaccine. She has not gone camping or hiking and
had no recent tick exposures. She has never used illicit drugs,
drinks alcohol rarely, and has never received a transfusion.
She is taking oral contraceptives but no other prescription
medication, and took 500 milligrams of Tylenol® once after
onset of her current symptoms. She has a pet cat but no other
animal exposures. She had chickenpox and mononucleosis
during childhood.
How does this information assist with the
diagnosis?
Lack of animal or tick exposures makes leptospirosis
and Rocky Mountain spotted fever unlikely, and Q fever
less likely. Yellow fever and typhoid fever are very unlikely
with no history of travel to rural endemic areas, and
assuming exposure occurred in Mexico, inconsistent with
the long incubation period. Hepatitis A virus (HAV),
hepatitis B virus (HBV), hepatitis C virus (HCV), and
hepatitis E virus (HEV) infection are all possible diag-
noses. A drug reaction to the oral contraceptive is a pos-
sible cause of hepatitis. The history of travel to an endemic
area makes hepatitis A the most likely diagnosis.
What diagnostic tests are needed?
Specific diagnostic serologic studies are necessary to
distinguish one form of viral hepatitis from another.
Testing for total (IgG+ IgM) anti-HAV does not distin-
guish between a past history of hepatitis A virus infec-
tion and current infection and is not useful in diagnosing
acute hepatitis A. Hepatitis A can be easily confirmed
with an anti-IgM anti-HAV test. This test is widely avail-
able and results are usually available within 24 hours. A
hepatitis panel is ordered, and results from such a panel
are shown here.
You obtain the following results from the serologic testing:
• Total anti-HAV: positive
• IgM anti-HAV: positive
• Total anti-HBc: positive




What is the diagnosis?
The diagnosis is hepatitis A. The hepatitis B serologic
tests indicate past, resolved infection with no chronic
infection. Acute hepatitis C is also possible; the appear-
ance of anti-HCV may be delayed for as long as 9 months
after exposure. However, with a confirmed diagnosis of
hepatitis A, further testing for HCV RNA is not indi-
cated at this point. Finally, note that hepatitis E is rarely
reported in travelers, and results of serologic tests for hepa-
titis E virus (HEV) are difficult to interpret. Tests for HEV
should only be performed if other more common causes
of hepatitis have been excluded.
The incubation period for hepatitis A is 15–50 days, with
an average of 28 days. The most common signs and symp-
toms associated with acute hepatitis A include jaundice, fever,
malaise, anorexia, and abdominal discomfort. The illness can
be severe and approximately 10% to 20% of reported cases
require hospitalization. The likelihood of having symptoms
with HAV infection is related to the person’s age. In children
<6 years of age, most (70%) infection is asymptomatic; if ill-
ness does occur it is not usually accompanied by jaundice.
Older children and adults are more likely to have symptom-
atic disease, although jaundice may be absent in as many as
one third of adults with HAV infection. In many developing
countries in Asia, Africa, and Central and South America,
infection is nearly universal during early childhood and is
often asymptomatic.
What treatment is indicated?
There is no specific treatment for hepatitis A. Bed rest
does not hasten recovery. Hepatitis A is never a chronic
infection, although 10% to 15% of symptomatic persons
have prolonged or relapsing disease lasting up to 6 months.
While rarely fatal in younger persons, the case-fatality rate
is nearly 2% among reported patients who are more than
50 years old. Following is a depiction of a typical course,
including times of peak fecal excretion of HAV, liver func-
tion test abnormalities, and clinical symptoms.
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How is hepatitis A virus transmitted, and
who is at risk for this disease?
HAV is an RNA virus that only infects primates. HAV
has a fecal-oral route of transmission and is easily trans-
mitted person to person. HAV is also transmitted through
contaminated food or water. Because HAV is present in
the blood during acute infection, bloodborne transmis-
sion is also possible, but rare. The highest levels of HAV
are found in the stool, and peak levels occur in the 2 weeks
before onset of illness.
Groups at increased risk for hepatitis A include travel-
ers to developing countries, men who have sex with men,
and injecting and noninjecting drug users. In the United
States, 4% to 6% of reported cases occur among interna-
tional travelers, many of whom presumably acquired HAV
infection from contaminated food or water. Approximately
50% of persons with hepatitis A do not report any known
risk factors, and some of these infections may be from
unrecognized transmission via HAV-contaminated food.
How might this illness have been
prevented?
Persons planning to travel to an endemic region should
receive hepatitis A vaccine or immune globulin before
departure. Hepatitis A vaccination can be given to any-
one 2 years of age and older, and has the advantage of
providing long-term protection (at least 20 years). Hepa-
titis A vaccine is an inactivated HAV preparation; the first
dose of vaccine provides protective anti-HAV levels within
30 days for >90% of vaccine recipients. Licensed hepati-
tis A vaccines available in the United States are consid-
ered to be equivalent in effectiveness, and include Havrix®
(manufactured by Glaxo SmithKline), VAQTA® (Merck
& Co.), and Twinrix® (combined hepatitis A and hepati-
tis B vaccine, Glaxo SmithKline). Vaccination is admin-
istered in a 2-dose schedule (0, 6 months) for Havrix®
and VAQTA®, and a 3-dose schedule (0, 1, 6 months)
for Twinrix®. The second (or third) dose is provided to
ensure protection in those who did not respond to the
first dose of vaccine. Ninety-nine percent of vaccinees will
be protected after 2 doses of vaccine.
For persons who present for hepatitis A immuno-
prophylaxis <30 days before departure to an endemic
region and for children <2 years old, immune globulin
(IG) is an effective means of preventing hepatitis A. IG is
the appropriate immunoprophylaxis for children <2 years
old. IG is a sterile preparation of concentrated antibodies
(immunoglobulins) made from pooled human plasma.
IG provides protection against hepatitis A for 3–5 months,
depending on dosage, through passive transfer of anti-
body. Vaccine and IG may be given simultaneously.
Hepatitis A is the most common vaccine-preventable dis-
ease among travelers. The risk varies according to region vis-
ited and the length of stay, and is increased even among
travelers who report observing measures to protect themselves
against enteric infection or stay only in urban areas. In the
United States, children account for approximately one third
of reported travel-related cases.
What else needs to be done?
Cases of hepatitis A should be reported to the local
health department immediately. The patient’s boyfriend
and any other household or sexual contacts whose last
exposure to the patient was <14 days ago should be given
IG. Screening for immunity before administering IG is
not recommended in this situation because it is more costly
than IG and would delay its administration. IG is not
indicated for family members or friends not living in the
household.
Prompt reporting of hepatitis A cases allows time to decide
on a course of action and provide timely immunoprophylaxis
when appropriate. Because this patient works as a food
preparer, the health department will need to visit the estab-
lishment to assess the likelihood that her duties and hygiene
practices pose a significant risk of food contamination. IG is
often recommended for co-workers of commercial food han-
dlers with hepatitis A. In addition, if she worked at any time
during the 2 weeks before onset of jaundice to 1 week after
onset, persons who ate food prepared or handled by this
patient may be candidates for IG prophylaxis. Determina-
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tions of the need for IG prophylaxis are made on a case-by-
case basis by experienced health department personnel. Again,
immediate reporting of hepatitis A cases allows time to decide
on a course of action and provide timely treatment and inter-
vention when appropriate.
Norovirus Infection: A Patient Scenario
Nancy is a 25-year-old previously well graduate student who
presents to the emergency department with a 12-hour history
of nausea, diarrhea, abdominal cramping, and vomiting (about
6 episodes), malaise, and a low-grade fever. She describes her
onset of symptoms as sudden.
Physical examination shows that Nancy is afebrile with a
supine blood pressure of 123/74 mm Hg. She has a diffusely
tender abdomen and is dehydrated. Stool examination is nega-
tive for occult blood.
What is the possible differential diagnosis
for her chief complaint?
• Infectious gastroenteritis
• Food intoxication (noninfectious gastroenteritis)
• Inflammatory bowel disease
• Appendicitis
• Pelvic inflammatory disease
What additional information would assist
with the diagnosis?
• Did anyone in her household experience similar illness
within the week prior to onset of symptoms?
• Has she been in contact with anyone outside her house-
hold with similar symptoms within the previous week?
• Has she had such symptoms before?
• Does she know if anyone else became ill?
• Has she traveled outside the United States within the
last month?
• Has she previously had a  sexually transmitted diseases
or does she have multiple sex partners?
Nancy reports that she rarely has diarrhea or vomiting. She
also reports no contact with anyone who was ill in the past
week, nor has she been out of the country in the past month.
Her boyfriend, who does not live with her, has similar symp-
toms with an almost identical onset time. Both attended a
wedding 2 days ago. The meal at the wedding reception, which
was held at a local reception hall, was the only meal they shared
in the past several days. Nancy does not know if anyone else
who attended the wedding became ill. Nancy reports that she
has no history of a sexually transmitted disease and that she
and her boyfriend have a monogamous sexual relationship.
How does this information assist with the
diagnosis?
Based on the rapid onset of symptoms, Nancy’s reported
past history of good health, and the fact that her boy-
friend has an almost identical history, inflammatory bowel
disease, appendicitis, and pelvic inflammatory disease are
the least likely diagnoses.
Food intoxication is also not very likely. Assuming that
the wedding reception was the source of the toxin, and
this was their most recent common meal, the time from
exposure to onset of symptoms is too long. Toxins usually
cause illness within minutes to hours after ingestion.
The most likely diagnosis is infectious gastroenteritis.
There is a possibility that Nancy’s and her boyfriend’s ill-
ness may be associated with an outbreak of gastroenteritis.
What additional information would assist
with the identification of the etiologic
agent?
• What sorts of foods were served at the wedding recep-
tion?
• When did the couple last share a meal prior to the wed-
ding reception?
• Has an outbreak of gastroenteritis associated with this
reception has been reported to the local health depart-
ment?. The health department may be able to aid in
determining what the etiologic agent was if it is cur-
rently investigating the outbreak.
At the wedding, the couple had a choice of meal. Nancy
had lobster tail and filet mignon. Her boyfriend had chicken.
They both consumed stuffed mushrooms, salad, and hors
d’oeuvres preceding the main meal. For dessert they both had
wedding cake and fresh fruit. Both drank wine or beer during
the reception.
The couple attended a barbecue the previous week. This
outing was a function sponsored by Nancy’s employer. Nancy
tells you that none of her co-workers have been ill with vom-
iting and diarrhea.
You place an inquiry with the local health department about
the possible outbreak. The health department notifies you that
an investigation is currently under way. Illness has also been
reported among 75% of attendees at a wedding the day
before the one Nancy attended, at the same reception hall.
The only common food between the 2 weddings is the salad,
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and the health department currently suspects a food handler
who worked during both weddings who was experiencing
diarrhea. Most patients have reported nausea, vomiting (about
90%), and diarrhea (70%), with some fever, malaise, head-
ache, chills, and abdominal pain. The mean incubation
period for those who have reported illness is 28.6 hours, with
a mean duration of 31.8 hours.
The health department suspects viral gastroenteritis caused
by a norovirus. A norovirus is suspected because of the rapid
onset of symptoms, the short 36-hour incubation period and
relatively short duration of illness, the absence of bloody diar-
rhea, and the high percentage of vomiting. Bacterial cultures
are negative for enteric pathogens on stool samples collected
thus far.
What are the complications of norovirus
infection?
Noroviruses are common causes of self-limiting acute
gastroenteritis, with illness frequently lasting no longer
than 60 hours. They commonly cause outbreaks in such
settings as restaurants, catered events, cruise ships, schools,
and nursing homes. The viruses can be spread person to
person through the fecal-oral route, through contaminated
food or water, or by raw or undercooked shellfish.
How should norovirus infections be
managed?
There is no antiviral agent that can be used to treat
norovirus infections. Supportive care such as oral or
intravenous fluids for rehydration should be provided.
To reduce the spread of illness, patients should be edu-
cated to use good hand washing practices, particularly
after using the bathroom and before preparing and han-
dling food.
The health department requests that a stool sample be col-
lected. The sample should be collected in a sterile container
without transport media, and kept at 4°C (40°F) until shipped.
The sample should be shipped on ice packs to the local health
department laboratory for testing. The health department also
asks you to encourage Nancy’s boyfriend to submit a stool
sample.
How could this norovirus infection have
been prevented?
The food handler with diarrhea should not have
returned to work for at least 24–48 hours after symptoms
subsided.
Proper hand washing procedures can prevent the spread of
the virus between persons.  Hands should be washed under




Andrea brings her 3-year-old son, Marcus, to your office
with a 2-day history of low-grade fever, nausea, and 6–8
watery stools per day. Marcus has also been complaining of
abdominal pain and feeling tired. He has been eating and
drinking less than usual. His medical history is remarkable
for recurrent otitis media, for which he was prescribed oral
antibiotics 10 days prior to this visit.
Physical examination reveals a well-developed boy who
appears fatigued. Vital signs are remarkable for low-grade
fever (99.5°F/37.5°C). He does not have signs of dehydra-
tion. His otitis appears resolved and he has a normal cardiop-
ulmonary exam. The abdominal exam reveals hyperactive
bowel sounds, mild diffuse tenderness, and stool negative for
occult blood.
What is the differential diagnosis




• Inflammatory bowel disease
• Antibiotic-associated colitis
What additional information would assist
with the diagnosis?
• Has he had similar symptoms before?
• Does he attend child care? If yes, have other children
attending the same care facility been ill with similar
symptoms?
• Has the child recently consumed a meal outside his
home; eg, at a birthday party or restaurant?
• Do other members of the household or close acquain-
tances have diarrhea or bloody diarrhea?
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• Has he traveled in the month prior to the onset of ill-
ness? If yes, where?
• Has he had contact with pet reptiles or farm animals or
visited petting zoos in the week prior to his symptom
onset?
Marcus has not had similar episodes of diarrhea in the past.
He attends preschool and is cared for by his grandmother
after school in her home. He last visited a petting farm 3
months prior to this illness. Their family returned the previ-
ous day from a 5-day Caribbean cruise. Marcus was diagnosed
with otitis media 4 days prior to their departure and was pre-
scribed a 1-week course of oral antibiotics. Andrea has had
nausea and 3–4 loose stools per day for the previous 2 days.
She has not had any fever, abdominal pain, or vomiting.
Marcus’ father and two sisters also traveled on the cruise and
are asymptomatic. None of the family members took prophy-
lactic antibiotics for travelers’ diarrhea during the cruise.
How does this information assist with the
diagnosis?
The additional history suggests that Marcus’ and
Andrea’s illness may be an infectious gastroenteritis
related to their recent travel. Antibiotic-associated colitis
caused by Clostridium difficile infection must be consid-
ered since the child was prescribed antibiotics for otitis 8
days prior to this illness. Given the recent onset, travel
history, and his mother’s symptoms, it is unlikely that
appendicitis, celiac disease, or inflammatory bowel dis-
ease are the etiologies of Marcus’ illness.
The most likely diagnosis is infectious gastroenteritis.
What additional historical information will
assist in the identification of the etiologic
organism?
• What foods did Marcus and Andrea consume in the pre-
vious week? In particular, which foods/ beverages did they
consume that the other family members did not?
• Did either Marcus or Andrea consume undercooked
meats, runny eggs, unpasteurized milk, raw shellfish,
or untreated water?
• Is there a reptile in the home?
• Marcus was prescribed antibiotics for otitis media 1 week
prior to the onset of his gastrointestinal symptoms. Has
Andrea been prescribed antibiotics during the month
prior to the onset of her diarrheal illness?
• Have there been other cases of diarrhea recognized in
the cruise ship travelers, in their community, or at
Marcus’ school?
An open-ended food history reveals multiple common meals
eaten by Andrea and Marcus. Andrea denies the consump-
tion of unpasteurized milk, raw shellfish, and undercooked
meats. She does report that, unlike the rest of the family, she
and Marcus used to wake up early enough to enjoy the break-
fasts served on board the cruise. Breakfast served on the cruise
consisted of a choice of French toast or pancakes with fruit
compote, scrambled eggs or omelets made to order, potatoes,
and fresh fruit along with a choice of beverages, including
milk, coffee, and tea. Andrea complained that the eggs were
occasionally runny. Several fellow passengers told Andrea at
breakfast that they were experiencing vomiting and diarrhea.
Andrea and Marcus ate the remainder of their meals with the
entire family. They did not drink any untreated water or eat
items purchased from street vendors at ports of call. In
response to your other questions, Marcus does not have a rep-
tile at home. Andrea has not been prescribed antibiotics for
more than 1 year. The family lives in a city and has access to
municipal water.
Based on the additional historical details, it appears that
many people on board the cruise were experiencing symp-
toms of vomiting and diarrhea. This suggests an outbreak of
infectious gastroenteritis that may be related to a common
food or water source on the ship. The etiologic agent may be
bacterial, viral, or parasitic. The most likely bacterial organ-
isms causing this diarrheal illness are Campylobacter jejuni,
Escherichia coli, Shigella species, and Salmonella. C. jejuni is
the most common bacterial cause of diarrheal illness in the
United States. Outbreaks of C. jejuni have been linked to raw
milk, poultry, eggs, and water. Enterotoxigenic E. coli (ETEC)
is recognized as the most common cause of “travelers’ diar-
rhea” and can be transmitted via food or water. Salmonella is
an important bacterial cause of foodborne illness, ranking just
behind C. jejuni in its frequency. Vehicles most commonly
implicated in foodborne outbreaks of salmonellosis include
beef, poultry, produce, eggs, pork, and dairy products. Large
waterborne outbreaks of salmonellosis have occurred rarely.
Why is identification of the cause of the
diarrhea important?
Identification of the cause of diarrhea in these two cases
is important because of the impact on treatment, identi-
fication of related cases, and detection of an outbreak and
identification of the responsible vehicle. Stool cultures
Vol. 53 / RR-4 Recommendations and Reports 21
should be performed to detect common bacterial patho-
gens such as Campylobacter, Salmonella, Shigella, or E. coli
O157:H7. Antimicrobial susceptibility results can guide
antibiotic therapy if a resistant organism is detected.
Additional testing may be conducted to detect nonbacte-
rial organisms. Stool examination for ova and parasites
(O&P) will reveal parasitic causes of foodborne and water-
borne illness such as Cyclospora cayetanensis. Rotavirus
infection, one of the most common etiologies of pediat-
ric diarrhea, may be diagnosed with enzyme immunoas-
say (EIA). The presence of fecal leukocytes suggests
bacterial infection but may be found in other infectious
or inflammatory states. Testing for the presence of Shiga
toxin to detect infection with enterohemorrhagic E. coli
(EHEC) would be appropriate if Marcus or Andrea had
bloody diarrhea.
What approaches would you take to
treating Marcus’ and Andrea’s illness?
Are antibiotics indicated for both Marcus
and Andrea? What other therapeutic
measures are useful for the management
of diarrheal illness?
Because Andrea’s symptoms are mild, she does not wish
to receive antibiotics. For Marcus, you prescribe
trimethoprim-sulfamethoxazole at appropriate doses. You
encourage Andrea to monitor for worsening fever, diar-
rhea, vomiting, and dehydration. You obtain stool speci-
mens for culture and O&P from both Marcus and Andrea
to confirm the etiologic agent.
The primary goal of therapy for Marcus and Andrea is
the maintenance of adequate hydration and electrolyte
balance. A commercial oral rehydration solution (ORS)
may be used, particularly for Marcus, to provide glucose
and salts. You encourage Andrea to give Marcus ORS to
prevent dehydration. Bismuth subsalicylate or loperamide
may be used to decrease the number of unformed stools
and shorten the duration of diarrhea, although neither is
available over the counter for children of Marcus’ age.
Loperamide should not be used in those patients who
develop fever or dysentery.
Finally, empiric antibiotic therapy can be used to treat
“travelers’ diarrhea,” which is most commonly caused by
ETEC, after obtaining the stool samples but prior to
obtaining results of stool cultures.
Three days after the initial visit, Andrea feels better with
fewer stools per day, but Marcus has had worsening vomiting
and diarrhea. He has had several episodes of high fever and
has not been drinking ORS adequately. In the office, Marcus
is febrile (102°F/38.8°C) and appears dehydrated with dry
mucous membranes and decreased skin turgor. No signifi-
cant change is noted in the abdominal examination. You
admit Marcus for intravenous hydration and encouragement
of oral rehydration and consider a change in antibiotic therapy.
Because of the progressive systemic nature of his illness, you
also obtain blood cultures at this time.
What information will guide your therapy
at this time?
The use of intravenous fluids to improve volume status
is reasonable given Marcus’ inability to maintain hydra-
tion with ORS. However, during hospitalization, he
should be encouraged to resume drinking ORS as early as
possible. The decision to change from oral to intravenous
antibiotics may be based on Marcus’ increased vomiting
and on his clinical decline. The choice of antibiotics should
reflect the results of stool culture and antimicrobial sensi-
tivities.
The laboratory reports the growth of Salmonella
Typhimurium from Marcus’ stool cultures. Susceptibility test-
ing reveals an organism resistant to multiple antibiotics,
including ampicillin and sulfamethoxazole. Multidrug-
resistant S. Typhimurium has been on the rise in the United
States since the early 1990s and now accounts for at least 25%
of these isolates. Definitive type 104 (DT 104), the most com-
mon phage type of multidrug-resistant S. Typhimurium, may
be responsible for more invasive disease than other phage types.
In an outbreak, resistant organisms appear to cause more cases
than do sensitive strains. Marcus’ recent exposure to antibiot-
ics for otitis media likely increased his susceptibility to Salmo-
nella infection, perhaps by decreasing the usual protection
offered by normal bowel flora, and thus decreasing the infec-
tious dose necessary to cause illness. In addition, he was placed
at increased risk for infection with a resistant strain of
S. Typhimurium if he was exposed while still taking the anti-
biotic.
Treatment of Salmonella gastroenteritis with antibiotic
therapy is controversial because of the resulting increase in
asymptomatic carriage, particularly among children less than
5 years of age. However, given the systemic nature of his ill-
ness, you choose to treat Marcus with several days of an intra-
venous third-generation cephalosporin. This is a reasonable
choice in light of the antimicrobial resistance and the reluc-
tance to use fluoroquinolones in the pediatric population.
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Should these cases be reported to the
local health department? What are the
public health implications of these two
cases of salmonellosis?
Salmonellosis is a nationally notifiable disease, and most
states require clinicians to report cases to local or state pub-
lic health agencies. The health department and its public
health partners can conduct studies to determine whether
these cases indicated an outbreak of salmonellosis aboard
the cruise ship. If an outbreak is confirmed, additional
investigation is necessary to identify the contaminated food
or the ill food worker infected with Salmonella, and whether
there were correctable food-handling errors. If a food
vehicle is identified, traceback and recall may be necessary
to remove it from the market and prevent the occurrence
of other cases. Given the increasing prevalence of drug-
resistant strains of S. Typhimurium, public health labora-
tories may perform bacteriophage typing or pulsed-field
gel electrophoresis (PFGE) to further characterize the drug-
resistance patterns of these organisms. Reporting of these
cases will contribute to essential nationwide surveillance of
salmonellosis, foodborne outbreaks, and antimicrobial
resistance.
What prevention measures will you
recommend to Marcus and Andrea? Are
repeat stool cultures necessary?
To prevent Salmonella infections, all meat and egg dishes
should be fully cooked. Andrea can purchase eggs that
are pasteurized in the shell, and irradiated ground beef
and poultry to reduce the risk of contamination. Basic
food safety practices in the kitchen can also help prevent
such infections, such as refrigerating leftovers promptly,
washing hands and utensils after contact with raw meat
and poultry, and keeping raw meat and poultry separate
from ready-to-eat foods. Marcus and Andrea should be
reminded to wash their hands with warm running water
and soap after using the bathroom and before and after
meals to avoid transmitting the infection to others. Marcus
is likely to have prolonged carriage of Salmonella in the
intestines. While he may return to preschool as soon as
he is feeling well enough to do so because direct spread
from one child to another is rare, clinicians should defer
to their local health departments regarding their clear-
ance policies for convalescing children attending pre-
school.
With adequate hydration and your chosen antimicrobial
therapy, Marcus will likely recover fully from this diarrheal
illness without residual complications.
Unexplained Illness: A Patient Scenario
You have been a primary care practitioner in Manhattan,
New York, for several years.  Jack, a 29-year-old otherwise
healthy male, has been your patient for the past year. At 8:00
a.m. he calls your triage nurse complaining of a very sudden
onset of nausea, cramps, coughing, and sweating. The nurse
is concerned about the suddenness of onset and wants to know
what you would like to do.
Should you have him call again later if he
does not improve? Should you have him
make an acute-visit appointment, or
should you send him to the emergency
room?
You are concerned about the suddenness of the onset of
symptoms but not the severity, so you decide to have him
come to the office immediately.
Jack presents in your office 30 minutes later. In addition to
nausea, cramps, coughing, and sweating, his eyes have begun
to tear uncontrollably and he complains of having had diffi-
culty breathing while en route to the office. Upon arrival, he
immediately asks to use the bathroom.
Jack reports that he started his morning routine as usual
with a run. Upon returning home, he finished drinking the
bottle of water he had purchased earlier from the local deli
and began to get ready for work. By the time he had finished
showering and dressing, he began to feel sick to his stomach.
He then developed cramping but no diarrhea. Shortly there-
after, he began to have bouts of coughing uncontrollably. He
does not know when the sweating started. He states that he
had difficulty breathing while en route to the office, and that
the tearing just started. He denies vomiting, hemoptysis,
hematuria, bright red blood per rectum (BRBPR), chills, fever,
headache, myalgia, arthralgia, or diarrhea. Jack also denies the
use of any medication, other drugs or alcohol. “That stuff
rots your gut.”
Jack reports that he finished his run at about 7:00 a.m. It is
now 9:00 a.m..
Despite having just urinated, he states that he must go again
and immediately. However, Jack experiences incontinence on
his way to the bathroom. Upon his return to the exam room,
you notice a slight tremor in his left arm. He states that this
has only just begun.
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What preliminary diagnosis can you make
at this point?
• An anxiety attack
• A viral syndrome
• A potential foodborne illness
• Anticholinergic poisoning
You are not ready to reach a conclusion at this point, so you
move to a physical exam and observe the following:
Objective:
Respiration rate: 20
BP: 92/60 mm Hg.
Heart rate: 50
Temperature: 98.6°F (37°C)
You note that Jack is anxious but oriented to time, place, and
person. His head, ears, eyes, nose, throat (HEENT) examina-
tion shows bilateral miosis and decreased reactivity. There are
no signs of trauma or bleeding. His heart has regular rate and
rhythm, no murmur, and good perfusion. Radial and dorsal
pulses are 2+. His lung examination reveals scattered wheez-
ing. His abdomen is soft, nontender, not distended, with
increased bowel sounds, and no mass. Extremities appear
within normal limits. The neurologic exam reveals the slight
tremor in his left arm, slightly slurred speech, excessive saliva-
tion, and transient fasciculations in both upper extremities.
You note negative Babinski and his cranial nerves (CN) 2-11
appear intact, while CN 12 appears slightly abnormal.
What other information would assist with
the diagnosis?
More history from Jack, including most recent activity
and diet.
You now seek additional history. Jack lives alone and does
not believe that he has been in contact with anyone who is ill.
He works in an office as a lawyer. His run takes him up 5th
Avenue and then over to 3rd Avenue, then back home. He
does not run through Central Park. He does not have plants
and does not garden as a hobby. His most recent meal was the
night before, about 10 hours prior to the onset of his symp-
toms. It consisted of boiled pasta, steamed broccoli, and olive
oil. He prepared the meal himself. He states that he carefully
washed the broccoli, the oil was from a bottle he opened last
week, and the pasta was from a box he had already used 2
days before. All he had to drink was tap water with dinner last
evening and the bottled water from this morning.
Jack’s presentation appears to involve
which of the following systems?
• Autonomic nervous system
• Lymphatic system
• Central nervous system
The signs and symptoms in Jack’s presentation predomi-
nantly involve increased autonomic responses, and are per-
haps progressing to include the central nervous system as well.
You decide that immediate treatment is called for and order
oxygen, atropine, and pralidoxime (2-PAM). Given that Jack
does not appear to have been exposed dermally, the most likely
route appears to have been oral. Therefore, you also appropri-
ately begin an IV with normal saline
What is the initial diagnosis?
This presentation is not consistent with bacterial, viral,
or parasitic food poisoning. While the signs and symp-
toms indicate acute organophosphate poisoning, the his-
tory provides no indication, and indeed seemingly
contradicts this theory because of the lack of exposure.
There has been no exposure to places where organophos-
phates are typically used, such as on lawns, house plants,
and parks. Nevertheless, Jack has presented with a fairly
classic case of organophosphate poisoning. Therefore,
ingestion must be considered. Since you have no sugges-
tion of deliberate ingestion on Jack’s part, it must be
assumed that he has consumed it unintentionally.
Organophosphate poisoning has an onset of 30 minutes to
2 hours. Jack has actually made it easy to identify the most
likely source: the only thing he has consumed in 10 hours is
water. The broccoli could have had pesticides on it that may
not have been removed when Jack washed it, but then he would
have developed his symptoms during the night. Taking into
account the temporal relationship between his ingestion of
the bottled water and the onset of his symptoms, the bottled
water seems the most likely candidate.
Given this information, what are key
questions you should consider?
• Is the water truly contaminated?
• If it is, how did it become contaminated?
• Who else may have ingested it?
• Who else is at risk?
• What action should be taken?
24 MMWR April 16, 2004
You realize that if your diagnosis and conclusions are
correct then a public health hazard may exist. Two things
need to be done. First, the health department must be
contacted, and second, tests need to be done that will
confirm your diagnosis. While the usual work-up for
organophosphate poisoning is clinical diagnosis, there are
assays available to measure cholinesterase activity in plasma
and red blood cells. It is also possible to detect some pes-
ticides in urine. You decide to order both tests as this will
provide the greatest insight into what the possible expo-
sure is for other people in Jack’s building, neighborhood,
or even his city.
When communicating with the local public
health department, whom should you ask
to speak to concerning this situation?
• The medical epidemiologist?
• The medical director?
• The infectious disease officer?
You ask to speak with the medical director. You present
Jack’s case, making careful note of the time course, and
also inform the medical director of your suspicions of the
source. The medical director takes this information and
agrees with your concerns. She then asks you to speak
with the chief epidemiologist so that an investigation can
begin.
In many large cities, there is a city health department;
in smaller cities or towns, it will usually be necessary to
contact the local or state health department. Try to match
the level with the greatest number of people who may
become affected. Other persons who may be of immedi-
ate help if you cannot reach the medical officer are the
epidemiologist or even an environmental health officer.
These people will most likely know what to do with the
information you have.
Most health departments across the country have been
working to increase their knowledge or at least their aware-
ness of the possibility of intentional contamination. Many
have also created positions solely devoted to this task.
Therefore, it is possible that you will be directed to such
an individual.
The health department initiates an investigation that
includes testing the water; looking for other cases of organo-
phosphate poisoning; interviewing the patient; notifying other
parts of the public health system, including law enforcement,
CDC, and the state health department. They may even issue
a public notice.
There is another possible cause for the case you have just
seen: sarin gas can cause a similar presentation. If sarin gas
had been sprayed into the air, it is possible that Jack could
have respiratory exposure to the nerve gas.
If this were true, how would it change
what you did?
Persons exposed to sarin, and possibly other nerve
agents, will have a clinical presenation similar to those
with organophosphate poisoning. Hence, medical man-
agement will likely be similar.
Finally, you are gratified to have helped detect a possible act
of contamination that could potentially harm or even kill a
great many people. Afterward, while making rounds in the
hospital that day you are told by a colleague that a number of
runners from a 5K race in Central Park this morning and
tourists visiting the Empire State Building were brought to
the emergency room complaining of sudden onset of nausea,
cramps, and coughing. It was reported that all had been drink-
ing bottled water.
Clinical Vignettes: What’s Your Call?
The following clinical vignettes are provided for your self-
evaluation. All are possible situations that may present at your
practice. The “Diagnostic Considerations” section and the
tables of etiologic agents that are also part of this primer will
provide the information necessary for you to adequately
address these clinical situations. Note that these vignettes
include both infectious and noninfectious forms of foodborne
illness.
For the following clinical vignettes, choose the best answer
from the choices listed at the end of the vignettes:
A — likely diagnosis; choose the best possible answer listed
on “answer selections” page under A selections.
B — most appropriate choice to confirm the diagnosis (there
may be more than one correct answer — list all of them).
Choose from the possible answers listed on “answer selections”
page under the B section.
Finally, decide whether the situation warrants reporting to
the local or state health department.
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Clinical Vignettes
I. You receive a long-distance call from a patient who is
an outdoorsman. He is with a group that collected
and ate some wild mushrooms less than 2 hours ago.
Several members of the group have since developed
vomiting, diarrhea, and some mental confusion.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
II. A newborn child has symptoms of sepsis. Cerebrospi-
nal fluid studies are consistent with meningitis. The
mother had a flu-like syndrome prior to delivery.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
III. This patient has just returned today from Latin
America following a 2-day business trip. He reports
having eaten several meals of fish that he bought from
street vendors around his hotel. He feels very ill with
profuse, watery diarrhea, and vomiting.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
IV. An 18-month-old child is brought to your office with
fever, bloody diarrhea, and some vomiting. She has
been drinking unpasteurized milk in the last 48 hours.
No other family members are ill.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
V. A patient calls and states that he and several family
members are ill with severe vomiting. They ate at a
church picnic 4 hours earlier.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
VI. A patient calls and states that most family members
have developed severe vomiting, about 1 hour after
eating at a picnic. They ate barbecued beef, chips,
potato salad, and homemade root beer. Some are com-
plaining of a metallic taste.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
VII. A patient has had chronic intermittent diarrhea for
about 3 weeks. There is no fever or vomiting and no
blood in the stool. The patient travels to Latin America
and Eastern Europe frequently, most recently 2 weeks
ago.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
VIII. The parents of a 6-month-old infant are concerned
because she is listless and weak. The infant is feeding
poorly, has poor head control, and is constipated.
There is no fever or vomiting.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
IX. A businessman who travels frequently is ill with
fatigue, jaundice, abdominal pain, and diarrhea. About
1 month ago, he returned from an international trip
during which he consumed raw oysters.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
X. Several members of a single family are ill with abdomi-
nal cramps and watery diarrhea. They just returned
from visiting friends on the East Coast of the United
States, where they consumed raw oysters 48 hours ago.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
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XI. A minister at a local church calls to report that many
members began experiencing watery diarrhea on the
morning after the annual turkey dinner fundraiser.
Some people also reported nausea and abdominal
cramps, but no one has fever or bloody stools.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XII. You receive a long-distance call from a patient on a
fishing vacation off the coast of Belize. Her family has
been eating a variety of local fish and shellfish that
they caught. She reports that several family members
developed abdominal pain, severe diarrhea, and weak-
ness the morning after they consumed the seafood for
dinner. One family member began having difficulty
speaking later on that same night.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XIII. A family in a rural community is worried that their
father may be having a stroke. He is complaining of
double vision and is having trouble swallowing. They
have a large garden and eat home-canned vegetables.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XIV. A 2-year-old child who attends day care presents with
abdominal cramps and severe bloody diarrhea, which
has been present for 2 days. He has no fever.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XV. Susan tells you that she has had diarrhea, nausea, and
abdominal cramping for almost 12 hours now. She
also presents with malaise and a low-grade fever and
informs you that as far as she can tell, the symptoms
developed very suddenly. Stool examination is nega-
tive for occult blood. Susan informs you that her good
friend is also sick and they both attended a company
picnic less than 2 days ago.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XVI. Sally arrives at your office with acute gastrointestinal
illness characterized by diarrhea, abdominal cramps,
chills, fever, and body aches. She also informs you
that about 3 days before she started getting sick, she
had consumed raw ground beef that was seasoned with
onions and an herb mix.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XVII. James presents to the emergency room with a low-
grade fever and complaining of fatigue and nausea for
the past 24 hours. He also describes his urine as being
dark and states that he has had 4 bowel movements in
the past 24 hours, all of which were light colored.
Upon further questioning, James says that he has no
history of jaundice and that he returned from a busi-
ness trip to the Philippines a month ago.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XVIII. You are halfway through your shift in the ER. There
are four patients, two adults and two children, with a
history of nausea, vomiting, abdominal pain, and pro-
fuse (especially in the children) watery diarrhea in the
absence of fever. They each report that these symp-
toms began 5 days ago and resolved after 1 day. They
had all been symptom free for 3 days, but now the
symptoms have returned. There is also a new onset of
jaundice and bloody diarrhea. Lab results indicate el-
evated LFTs. The patients do not know each other,
but all report eating hamburgers several hours before
the initial onset of symptoms.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
XIX. A mother has brought in a 5-month-old child with ap-
parent blindness. She reports that the child had been
healthy until the past month when the vision problems
appeared. The mother states that she had been well dur-
ing the pregnancy, but further questioning reveals that
the mother had two young cats at home for which she
was the sole care provider. The cats were given away
just before the birth of the child because of concerns
about the child being smothered by the cats.
A — likely diagnosis:
B — most appropriate test to confirm etiology/follow-up
action:
Report to the health department? ___Yes  ___No
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Answer Choices
A: Choose from any of these possible etiologies:
1. Intoxication from preformed toxins of Staphylococcus
aureus or Bacillus cereus
2. Intoxication from toxins produced in vivo by Clostridium
perfringens
3. Salmonella or Campylobacter are possible.
4. E. coli O157:H7
5. Noroviruses, Vibrio parahaemolyticus, and other Vibrio
infections
6. Vibrio cholerae infection
7. Botulism must be ruled out
8. Listeria monocytogenes sepsis
9. Cryptosporidium parvum
10. Cyclospora cayetanensis
11. A form of metal poisoning
12. A form of mushroom poisoning
13. Likely fish/shellfish toxin
14. Giardia lamblia
15. Trichinella spiralis
16. Hepatitis A virus
17. Congenital toxoplasmosis
18. Intentional amanitin poisoning
B: Choose from any of these following tests/actions
1. Clinical diagnosis; laboratory tests may not always
be indicated.
2. Generally detected on routine stool cultures.
3. Generally, a reference laboratory is needed to iden-
tify the toxin from food, stool, or vomitus.
4. Important to identify causative organism for public
health reasons.
5. Send stool samples to health department (Vibrio
cholerae, other vibrios, E. coli O157:H7, special toxin
tests, Clostridium perfringens, Clostridium botulinum).
6. Not detected by routine stool cultures (E. coli
O157:H7, Vibrio cholerae, other vibrios).
7. Should test for viral agents.
8. For cysts, ova, and parasite detection, at least 3 stool
samples must be collected. Sometimes the organism
may still be missed.
9. Test for appropriate metal.
10. Special test needed to identify a fish toxin.
11. Consult a mycologist to identify the mushroom.
12. Blood culture is the best source for diagnosis.
13. Blood test helpful to identify the agent.
14. May need acute and convalescent serum or viral
cultures.
15. Isolation of T. gondii from infant blood. PCR of white
blood cells or CSF, or IgM and IgA serology, per-
formed by a reference laboratory.
16. Rapid and aggressive antitoxin therapy. There is no
single effective antidote at this time, but silibinin (with
penicillin G) and N acetyl cysteine are showing prom-




CDC Food Safety Information
http://www.cdc.gov/foodsafety
Continuing Medical Education (CDC)
http://www2.cdc.gov/mmwr/cme/conted.html
US Government Food Safety Information Gateway
http://www.foodsafety.gov
Fight BAC!™ Education Campaign
http://www.fightbac.org
Foodborne Illness Education Information Center
http://www.nal.usda.gov/fnic/foodborne/foodborn.htm
Public Health Partners — Networks and Resources
http://www.cdc.gov/other.htm
Bad Bug Book (FDA)
http://www.cfsan.fda.gov/~mow/intro.html
Travelers’ Health Information (CDC)
http://www.cdc.gov/travel
Question Choice(s) Choice(s) Report to
number for A for B Health Dept.?
I 12 11 Yes
II 8 12 Yes
III 6 5,6 Yes
IV 3,4 2 Yes
V 1 1,3 Yes
VI 11 9 Yes
VII 14 8 Yes
VIII 7 5 Yes
IX 16 13,7,14 Yes
X 5 5,6,7 Yes
XI 2 1,5 Yes
XII 13 10 Yes
XIII 7 3,5 Yes
XIV 4 5,6 Yes
XV 3,5 5,6,7 Yes
XVI 3,4 2 Yes
XVII 16 13,7,4 Yes
XVIII 18 16, Yes (intentional
contamination?)
XIX 17 15,13 Yes
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Listing of foodborne diseases, pathogens and toxins (CDC)
http://www.cdc.gov/foodsafety/disease.htm
Searchable database: U.S. Foodborne Disease Outbreaks,
1990–1995
www2.cdc.gov/ncidod/foodborne/fbsearch.asp
Terrorism and Public Health (CDC)
http://www.bt.cdc.gov/
Professional Organizations
American Academy of Family Physicians
http://www.aafp.org
American Medical Association (AMA)
http://www.ama assn.org
Infectious Diseases Society of America
http://www.idsociety.org
American Academy of Pediatrics
http://www.aap.org
American Nurses Association (ANA)
http://www.nursingworld.org




State and Local Organizations
Association of Food and Drug Officials
http://www.afdo.org
Association of State and Territorial Directors of Health Pro-
motion and Public Health Education
http://www.astdhpphe.org
Association of Public Health Laboratories (APHL)
http://www.aphl.org
Association of State and Territorial Health Officials
(ASTHO)
http://www.astho.org
Council of State and Territorial Epidemiologists (CSTE)
http://www.cste.org
National Public Health Information Coalition (NPHIC)
http://www.nphic.org




US Department of Agriculture (USDA) Food Safety and
Inspection Service
http://www.fsis.usda.gov
US Department of Health and Human Services (DHHS):
Centers for Disease Control and Prevention
http://www.cdc.gov
US Food and Drug Administration
http://www.fda.gov
Center for Food Safety and Applied Nutrition (CFSAN)
Information for Health Professionals
http://www.cfsan.fda.gov/~dms/hpro-toc.html
State and local government agencies
http://www.foodsafety.gov/~fsg/fsggov.html
Role of Government Agencies in Food Safety
http://vm.cfsan.fda.gov/~lrd/foodteam.html
Gateway to government food safety information
http://www.foodsafety.gov
Reports and Journals
CDC, Morbidity and Mortality Weekly Report
http://www.cdc.gov/mmwr
CDC, Emerging Infectious Diseases Journal
http://www.cdc.gov/eid
Food Safety Education Resources
An Ounce of Prevention Keeps the Germs Away
http://www.cdc.gov/ncidod/op
Attention Pregnant Women: What you can do to keep germs
from harming you and your baby
http://www.cdc.gov/foodsafety/edu.htm
Consumer Advice from CFSAN
http://www.cfsan.fda.gov/~lrd/advice.html
Cooking for Groups: A Volunteer’s Guide to Food Safety
www.fsis.usda.gov/OA/pubs/cfg/cfg.htm
Fight BAC: Keep Food Safe From Bacteria
http://www.fightbac.org
Food Safety Resources for Kids, Teens and Educators
http://www.foodsafety.gov/~fsg/fsgkids.html
For Kids, Teens, and Educators
http://www.cfsan.fda.gov/~dms/educate.html
Hand Hygiene in Healthcare Settings
http://www.cdc.gov/handhygiene
Healthy Pets, Healthy People
http://www.cdc.gov/healthypets
Healthy Schools, Healthy People — It’s a SNAP
http://www.ItsASnap.org
Listeriosis and Pregnancy: What is Your Risk?
http://www.fsis.usda.gov/OA/pubs/lm_tearsheet.htm
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Thinking Globally, Working Locally: A Conference on Food
Safety Education
http://www.fsis.usda.gov/Orlando2002
To Your Health: Food Safety for Seniors
http://www.foodsafety.gov/%7Efsg/sr2.html
Toxoplasmosis: An important message for pregnant women
http://www.cdc.gov/ncidod/dpd/parasites/toxoplasmosis/
ToxoWomen.pdf
Food Safety Education Partnerships
Clean Hands Coalition
Email to: cleanhands@cdc.gov
Food Safety Training and Education Alliance
http://www.FSTEA.org
National Coalition for Food Safe Schools
http://www.FoodSafeSchools.org
Partnership for Food Safety Education
http://www.fightbac.org
Canadian Partnership for Consumer Food Safety Education
http://www.canfightbac.org
Toll-free Information Phone Numbers
USDA Meat and Poultry Hotline:
1-800-535-4555
FDA Safe Food Hotline:
1-888-SAFE FOOD (723-3366)




AMA Resources on Disaster Preparedness and Emergency
Response
http://www.ama-assn.org/go/disasterpreparedness
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Continuing Education Activity Sponsored by CDC
Diagnosis and Management of Foodborne Illnesses
You must complete and return the response form electronically or by mail by
April 16, 2007, to receive continuing education credit. If you answer all of
the questions, you will receive an award letter for 2.75 hours Continuing
Medical Education (CME) credit; 0.25 Continuing Education Units (CEUs);
3.0 hours Certified Health Education Specialist (CHES) credit; or 3.3 contact
EXPIRATION — April 16, 2007
hours Continuing Nursing Education (CNE) credit. If you return the form
electronically, you will receive educational credit immediately. If you mail the
form, you will receive educational credit in approximately 30 days. No fees are
charged for participating in this continuing education activity.
By Internet
1. Read this MMWR (Vol. 53, RR-4), which contains the correct answers to
the questions beginning on the next page.
2. Go to the MMWR Continuing Education Internet site at <http://www.
cdc.gov/mmwr/cme/conted.html>.
3. Select which exam you want to take and select whether you want to register
for CME, CEU, CNE, or CHES credit.
4. Fill out and submit the registration form.
5. Select exam questions. To receive continuing education credit, you must
answer all of the questions. Questions with more than one correct answer
will instruct you to “Indicate all that apply.”
6. Submit your answers no later than April 16, 2007.
7. Immediately print your Certificate of Completion for your records.
By Mail or Fax
1. Read this MMWR (Vol. 53, RR-4), which contains the correct answers to
the questions beginning on the next page.
2. Complete all registration information on the response form, including your
name, mailing address, phone number, and e-mail address, if available.
3. Indicate whether you are registering for CME, CEU, CNE, or CHES credit.
4. Select your answers to the questions, and mark the corresponding letters on
the response form. To receive continuing education credit, you must
answer all of the questions. Questions with more than one correct answer
will instruct you to “Indicate all that apply.”
5. Sign and date the response form or a photocopy of the form and send no
later than April 16, 2007, to
Fax: 404-639-4198  Mail: MMWR CE Credit
Office of Scientific and Health Communications
Epidemiology Program Office, MS C-08
Centers for Disease Control and Prevention
1600 Clifton Rd, N.E.
Atlanta, GA 30333
6. Your Certificate of Completion will be mailed to you within 30 days.
INSTRUCTIONS
ACCREDITATION
Continuing Medical Education (CME). This activity has been planned and implemented in accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education through joint sponsorship of CDC; the Food Safety and Inspection Service, U.S. Department of
Agriculture; and the Center for Food Safety and Applied Nutrition, Food and Drug Administration. CDC is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CDC designates this educational activity for a maximum
of 2.75 hours in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually
spent in the educational activity.
Continuing Education Unit (CEU). CDC has been approved as an authorized provider of continuing education and training programs by the
International Association for Continuing Education and Training and awards 0.25 Continuing Education Units (CEUs).
Continuing Nursing Education (CNE). This activity for 3.3 contact hours is provided by CDC, which is accredited as a provider of continuing education
in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.
Certified Health Education Specialist (CHES). CDC is a designated provider of continuing education contact hours in health education by the
National Commission for Health Education Credentialing, Inc. This program is a designated event for CHES to receive 3.0 hours in category 1 credit in health
education, CDC provider number GA0082.
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1. Which of the following provide important clues to the possible
etiology of a food-associated illness?
A. Incubation period.
B. Duration of illness.
C. Predominant clinical signs and symptoms (e.g., vomiting, diarrhea,
and abdominal pain).
D. Travel history.
E. All of the above.
2. Which group is at higher risk for complications from foodborne
illness?
A. Persons with weakened immune systems.
B. Persons with liver disease.
C. Pregnant women.
D. Older adults.
E. All of the above.
3. Which of the following is not a safe food-handling behavior?
A. Using the same cutting board for raw foods and cooked foods.
B. Using a food thermometer to check the internal temperature of food
before eating it.
C. Rinsing raw produce with water.
D. Washing hands before and after handling food.
4. What is the appropriate method to use in determining if a hamburger
is cooked to a proper temperature?
A. Cooking it until it is brown inside.
B. Using a food thermometer to ensure that the internal temperature
reaches 160ºF.
C. Determining if a hamburger is cooked to a proper temperature is not
necessary because it is too small.
D. Taking a bite of the hamburger to ensure that it tastes cooked.
5. When a foodborne outbreak is suspected, who would be a helpful
contact at the health department?
A. Medical officer.
B. Epidemiology officer.
C. Environmental health officer.
D. Any of the above would be helpful.
6. Which of the following is not consistent with inflammatory diarrhea?
A. Presence of fecal leukocytes.
B. Grossly bloody stool.
C. Infection with invasive or cytotoxigenic bacterial and protozoan
species.
D. Involvement of the small intestine.
7. If a foodborne illness is suspected, which of the following should be
considered?
A. Submission of appropriate specimens for laboratory testing.
B. Contacting the state or local health department.
C. Initiating oral rehydration therapy.
D. All of the above.
Goal and Objectives
This MMWR provides recommendations for physicians and other health-care professionals who have a critical role in diagnosing, treating, and reporting food-related
disease outbreaks. These recommendations were developed by the American Medical Association, the American Nurses Association-American Nurse Foundation,
the Centers for Disease Control and Prevention, the Food and Drug Administration’s Center for Food Safety and Nutrition, and the United States Department of
Agriculture’s Food Safety and Inspection Service. The goal of this report is to provide health-care providers with guidance and patient-education materials regarding
foodborne illness. After completing this continuing education activity, the reader should be able to 1) differentiate between the six etiologic agents that should be
considered regarding manifestations of foodborne illness; 2) describe four criteria to consider when treating a diagnosed foodborne illness; 3) summarize the reporting
requirements for foodborne illness; and 4) identify three groups of persons who are at higher risk for foodborne illnesses.
To receive continuing education credit, please answer all of the following questions:
8. Intentional contamination of food is uncommon, but which of the
following would make you suspect that such an act had occurred (i.e.,
the unusual nature of the situation would induce suspicion of
intentional contamination)?
A. An unusual agent or pathogen in a common food.
B. A common agent or pathogen affecting an unusually large number of
persons.
C. A common agent or pathogen that is uncommonly seen in clinical
practice.
D. All of the above.
9. Multidrug-resistant Salmonella typhimurium cases . . .
A. have been on the rise in the United States since the 1990s.
B. might be responsible for more invasive disease than other types.
C. often are resistant to ampicillin and sulfamethoxazole.
D. cause more cases in an outbreak than do sensitive strains.
E. all of the above.
10. Norovirus infection, which often results in nausea, vomiting, and
watery/large-volume diarrhea within 24–48 hours, can be caused by . . .
A. inadequately cooked shellfish.
B. inadequately cooked hamburger.
C. ready-to-eat foods (e.g. salads).
D. iced drinks.
E. A, C, and D are correct.
11. Indicate your work setting.
A. State/local health department.
B. Other public health setting.
C. Hospital clinic/private practice.
D. Managed care organization.
E. Academic institution.
F. Other.






13. I plan to use these recommendations as the basis for . . . (Indicate all
that apply.)
A. health education materials.
B. insurance reimbursement policies.
C. local practice guidelines.
D. public policy.
E. other.



























































































14. Each month, approximately how many patients with a foodborne







15. How much time did you spend reading this report and completing the
exam?
A. <2.0 hours.
B. >2.0 hours but <3.0 hours.
C. >3.0 hours but <4.0.
D. >4.0 hours.
16. After reading this report, I am confident I can differentiate between
the six etiologic agents that should be considered regarding
manifestations of foodborne illness.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
17. After reading this report, I am confident I can describe four criteria to
consider when treating a diagnosed foodborne illness.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
18. After reading this report, I am confident I can summarize the
reporting requirements for foodborne illness.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
19. After reading this report, I am confident I can identify three groups of
persons who are at higher risk for foodborne illnesses.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
20. The objectives are relevant to the goal of this report.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
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Correct answers for questions 1–10.
1. E; 2. E; 3. A; 4. B; 5. D; 6. D; 7. D; 8. D; 9. E; 10. E.




C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
23. These recommendations will affect my practice.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
24. The content of this activity was appropriate for my educational needs.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
25. The availability of continuing education credit influenced my
decision to read this report.
A. Strongly agree.
B. Agree.
C. Neither agree nor disagree.
D. Disagree.
E. Strongly disagree.
26. How did you learn about this continuing education activity?
A. Internet.
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